Chris Hanson

Background

About Chris Hanson

Chris is a Senior Director, Finance + Accounting, Assistant Controller at Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Highlights: 5 significant system implementations since 2017 - Global Shares (a J.P. Morgan subsidiary) for Genmab's Equity (RSU and Warrant) Programs - 2023 - SAP ERP for Global financial reporting and accounting - 2023 - Clearwater for consolidation, accounting, reporting and analytics of investment portfolio - 2021 - Adaptive Insights for FP & A automation, consolidation- 2019 - Workday ERP and HR Solution - 2019 US IPO - IPO on Nasdaq US making Genmab a dual-listed entity on Nasdaq Copenhagen and Nasdaq in the US - 2019 Since joining Genmab in 2017, Chris has been part of the building process at Genmab from 10 employees in the US and 250 globally, to over 900 employees in the US and over globally, and experience in all areas within Genmab Finance including Accounting Operations, FP & A, Treasury, Tax, Internal and External Reporting, Internal Audit, etc. Prior to Genmab, Chris was an experienced Manager in the Philadelphia office of PwC serving clients within the Insurance & Banking industry with experience working on P&C, life insurance, health insurance, and mortgage insurance clients including Public (10K) and Non-Public audits, interim reviews, and statutory audits. Chris also spent time on Employee Benefit Plan audits for Defined Benefit and Defined Contribution Plans, and SSAE 16 assurance engagements with the Risk Assurance (IT team) at PwC with significant exposure to cross lines of service. Chris received his undergraduate degree in accounting at LaSalle University. Chris is a Certified Public Accountant licensed in the state of Pennsylvania. Chris is a member of the AICPA and PICPA.